Work

Xenograft-directed personalized therapy for a patient with post-transplant relapse of ALL

Year: 2016

Type: article

Source: Bone Marrow Transplantation

DOI: 10.1038/bmt.2016.122

Authors: T N Trahair, R B Lock, R Sutton, K C S Sia, K Evans, J Richmond, T Law, N C Venn, J A Irving, S Moore, E Nievergall, P Dang, S L Heatley, D L White, T Revesz

Institutions: UNSW Sydney, Sydney Children's Hospital, Newcastle University, South Australia Pathology, South Australian Health and Medical Research Institute, The University of Adelaide, Women's and Children's Hospital

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Sanofi, Leukaemia and Lymphoma Research, University of New South Wales, National Institutes of Health, Medical Research Council, National Health and Medical Research Council, National Cancer Institute

Awards: Pediatric Preclinical Testing Program, G1628177865, Translational research initiatives in acute leukaemia, Screening and targeting newly discovered genetic lesions in poor risk adult and childhood ALL

OpenAlex ID: W2401089748

FWCI: 1.653

Cites: 15

Cited by: 5

Related to: 10